SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001628280-19-011252
Filing Date
2019-08-28
Accepted
2019-08-28 16:39:34
Documents
2
Period of Report
2019-04-30
Effectiveness Date
2019-08-28

Document Format Files

Seq Description Document Type Size
1 DEF 14A schedule14aproxy2019.htm DEF 14A 455869
2 proxycardinfoa03.jpg GRAPHIC 5043
  Complete submission text file 0001628280-19-011252.txt   464327
Mailing Address 855 N. WOLFE STREET SUITE 619 BALTIMORE MD 21205
Business Address 855 N. WOLFE STREET SUITE 619 BALTIMORE MD 21205 410-369-0365
CHAMPIONS ONCOLOGY, INC. (Filer) CIK: 0000771856 (see all company filings)

IRS No.: 521401755 | State of Incorp.: DE | Fiscal Year End: 0430
Type: DEF 14A | Act: 34 | File No.: 001-11504 | Film No.: 191062420
SIC: 2836 Biological Products, (No Diagnostic Substances)